Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

NCT00853021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: bevacizumab

Sponsor

Jorge A. Garcia, MD

Collaborators

[object Object]